These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Selection of new lactic acid bacteria strains bearing probiotic features from mucosal microbiota of healthy calves: Looking for immunobiotics through in vitro and in vivo approaches for immunoprophylaxis applications. Sandes S; Alvim L; Silva B; Acurcio L; Santos C; Campos M; Santos C; Nicoli J; Neumann E; Nunes Á Microbiol Res; 2017 Jul; 200():1-13. PubMed ID: 28527759 [TBL] [Abstract][Full Text] [Related]
10. Mucosal vaccination and therapy with genetically modified lactic acid bacteria. Wells J Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390 [TBL] [Abstract][Full Text] [Related]
11. [Adhesion of lactic acid bacteria to epithelium of different cavities of the human organism]. Kovalenko NK; Podgorskiĭ VS; Kasumova SA Mikrobiol Z; 2004; 66(4):62-8. PubMed ID: 15515903 [TBL] [Abstract][Full Text] [Related]
12. Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option. Wang M; Gao Z; Zhang Y; Pan L Appl Microbiol Biotechnol; 2016 Jul; 100(13):5691-701. PubMed ID: 27154346 [TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route. Oh SH; Kim SH; Jeon JH; Kim EB; Lee NK; Beck S; Choi YJ; Kang SK Vaccine; 2021 Jul; 39(30):4072-4081. PubMed ID: 34127296 [TBL] [Abstract][Full Text] [Related]
14. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272 [TBL] [Abstract][Full Text] [Related]
16. Lactic acid bacteria as oral delivery systems for biomolecules. Berlec A; Ravnikar M; Strukelj B Pharmazie; 2012 Nov; 67(11):891-8. PubMed ID: 23210237 [TBL] [Abstract][Full Text] [Related]
17. Lactic acid bacteria protect human intestinal epithelial cells from Staphylococcus aureus and Pseudomonas aeruginosa infections. Affhan S; Dachang W; Xin Y; Shang D Genet Mol Res; 2015 Dec; 14(4):17044-58. PubMed ID: 26681052 [TBL] [Abstract][Full Text] [Related]
18. Genetic transformation of novel isolates of chicken Lactobacillus bearing probiotic features for expression of heterologous proteins: a tool to develop live oral vaccines. Mota RM; Moreira JL; Souza MR; Horta MF; Teixeira SM; Neumann E; Nicoli JR; Nunes AC BMC Biotechnol; 2006 Jan; 6():2. PubMed ID: 16396687 [TBL] [Abstract][Full Text] [Related]
19. New strategies for using mucosal vaccination to achieve more effective immunization. Walker RI Vaccine; 1994 Apr; 12(5):387-400. PubMed ID: 8023545 [TBL] [Abstract][Full Text] [Related]
20. Recombinant lactic acid bacteria as delivery vectors of heterologous antigens: the future of vaccination? Trombert A Benef Microbes; 2015; 6(3):313-24. PubMed ID: 25245573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]